Information about the Successful Completion of USFDA Inspection at JSTL under Regulation 30 of SEBI (LODR) Regulations, 2015.

Ss Jeevan Scientific Technology Limited @ %»n//o/% améé} andd bverse sobitions Ref: JSTL/BOD/BSE/2026-27/JUL26 Date: July 24, 2026. The Manager BSE Limited P. 1. Towers, Dalal Street Mumbai-400001. (BSE Scrip Code: 538837) Dear Sir/Madam, Sub: Information about the successful completion of USFDA inspection at ISTL under Regulation 30 of SEBI (LODR) Regulations, 2015. Ref: Scrip Code: 538837, Jeevan Scientific Technology Limited This is to bring to your kind notice that the United States Food and Drug Administration (USFDA) conducted an inspection of our Bioanalytical Facility, at Manikonda, Hyderabad. The purpose of the inspection was to review the BA/BE studies as well as the operations, systems and procedures. The inspectors started the review on 20% July, 2026 and closed on 24% July, 2026. We are pleased to inform you that the inspectors closed the inspection with No Observations (Zero 483s). The inspector concluded that the entire JSTL team is well trained, knowledgeable and experienced with International Regulatory requirements and Good practices, working within an adequately designed infrastructure and that the organization is compliant with all applicable regulations. This is for your information. Yours faithfully, For JEEVAN SCIENTIFIC TECHNOLOGY LIMITED Krishna Sainadh Kodati Company Secretary & Compliance Officer Registered Office: Plot No. 1&2, Sai Krupa Enclave, Near Lanco Hills, Golconda Post, Hyderabad- 500 008, T.S., India. Tel: +91-40-67364700 Email: info@jeevanscientific.com Web: www.jeevanscientific.com CIN: L72200TG1999PLC031016